Zhao, Jianyun <br/><br/>
Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells.  [electronic resource] 

 -  Oncotarget  Jun 2016 
 - 34785-99 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.9185  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Bridged Bicyclo Compounds, Heterocyclic--pharmacology<br/>Cell Line, Tumor<br/>Checkpoint Kinase 1--antagonists & inhibitors<br/>DNA Damage--drug effects<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>G2 Phase Cell Cycle Checkpoints--drug effects<br/>HL-60 Cells<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Mitosis--drug effects<br/>Myeloid Cell Leukemia Sequence 1 Protein--metabolism<br/>Phenylurea Compounds--pharmacology<br/>Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors<br/>Pyrazines--pharmacology<br/>Sulfonamides--pharmacology<br/>THP-1 Cells<br/>U937 Cells